Intro

This chapter explores a pioneering clinical trial that reveals the positive impact of immunotherapy before surgery on lung cancer survival rates. It discusses the progress made in cancer treatment, particularly for stage four patients, and the transition from conventional chemotherapy to cutting-edge immunotherapy.